STOCK TITAN

[Form 4] W.W. Grainger, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Susan Slavik Williams, a director of W.W. Grainger, Inc. (GWW), reported transactions on 09/01/2025 showing a sale and multiple beneficial ownership entries. The filing discloses a disposal of 8,342 shares of Grainger common stock and an acquisition of 5 deferred stock units expected to settle one-for-one into common shares after director service ends. The report lists total beneficial holdings across direct and indirect accounts, including 5,132 shares held directly in trust, multiple trusts holding 48,939, 200,314, 572, and 852,158 shares, and LLC-held positions of 1,528,585 and 150,000 shares, with certain trusts managed by Ms. Williams or her husband and with disclaimers of beneficial ownership where noted.

Susan Slavik Williams, membro del consiglio di amministrazione di W.W. Grainger, Inc. (GWW), ha segnalato operazioni il 01/09/2025 che mostrano una vendita e varie voci di proprietà beneficiaria. La dichiarazione indica la cessione di 8.342 azioni ordinarie Grainger e l'acquisizione di 5 unità azionarie differite, che dovrebbero convertirsi in azioni ordinarie in proporzione 1:1 al termine del mandato da direttrice. Il rapporto specifica le detenzioni complessive dirette e indirette, incluse 5.132 azioni detenute direttamente in trust, diversi trust con 48.939, 200.314, 572 e 852.158 azioni, e posizioni detenute da LLC pari a 1.528.585 e 150.000 azioni, con alcuni trust gestiti dalla signora Williams o dal marito e con i relativi disclaimer di proprietà beneficiaria dove indicati.

Susan Slavik Williams, directora de W.W. Grainger, Inc. (GWW), informó transacciones el 01/09/2025 que muestran una venta y varias entradas de propiedad beneficiaria. La presentación revela la enajenación de 8.342 acciones ordinarias de Grainger y la adquisición de 5 unidades de acciones diferidas, que se espera se conviertan una a una en acciones ordinarias al finalizar su cargo como directora. El informe enumera las participaciones totales directas e indirectas, incluidas 5.132 acciones mantenidas directamente en un fideicomiso, varios fideicomisos con 48.939, 200.314, 572 y 852.158 acciones, y posiciones en LLC de 1.528.585 y 150.000 acciones, con algunos fideicomisos administrados por la Sra. Williams o su cónyuge y con las renuncias de propiedad beneficiaria donde se indica.

W.W. Grainger, Inc.(GWW) 이사인 수잔 슬라빅 윌리엄스가 2025-09-01에 매도 및 여러 수익적 소유권 항목을 보고했습니다. 제출서는 Grainger 보통주 8,342주 처분과 5개의 이연주식단위 취득을 공시했으며, 이 단위들은 이사 임기 종료 시 1대1로 보통주로 정산될 예정입니다. 보고서는 직접·간접 계좌 전체 보유를 나열하며, 신탁에 직접 보유된 5,132주, 각기 48,939, 200,314, 572, 852,158 주를 보유한 여러 신탁, 그리고 LLC가 보유한 1,528,585주 및 150,000주 포지션을 포함하고 일부 신탁은 윌리엄스 씨 또는 그녀의 남편이 관리하며 명시된 경우 수익적 소유권 포기에 대한 고지가 있습니다.

Susan Slavik Williams, administratrice de W.W. Grainger, Inc. (GWW), a déclaré des opérations le 01/09/2025 faisant état d’une vente et de plusieurs éléments de propriété bénéficiaire. Le dépôt révèle la cession de 8 342 actions ordinaires Grainger et l’acquisition de 5 unités d’actions différées, qui devraient être converties au pair en actions ordinaires à la fin de son mandat d’administratrice. Le rapport énumère les avoirs totaux directs et indirects, y compris 5 132 actions détenues directement en trust, plusieurs trusts détenant 48 939, 200 314, 572 et 852 158 actions, et des positions détenues par des LLC de 1 528 585 et 150 000 actions, certains trusts étant gérés par Mme Williams ou son époux et comportant des déclarations de non-ingérence de propriété bénéficiaire le cas échéant.

Susan Slavik Williams, Direktorin von W.W. Grainger, Inc. (GWW), meldete am 01.09.2025 Transaktionen, die einen Verkauf und mehrere Angaben zur vorteilhaften Inhaberschaft zeigen. Die Meldung weist die Veräußerung von 8.342 Aktien der Grainger-Stammaktien und den Erwerb von 5 aufgeschobenen Aktieneinheiten aus, die voraussichtlich nach Beendigung des Direktoramts eins zu eins in Stammaktien umgewandelt werden. Der Bericht listet die gesamten direkten und indirekten Bestände auf, darunter 5.132 Aktien direkt in einem Trust gehalten, mehrere Trusts mit 48.939, 200.314, 572 und 852.158 Aktien sowie LLC-Bestände von 1.528.585 und 150.000 Aktien, wobei bestimmte Trusts von Frau Williams oder ihrem Ehemann verwaltet werden und dort, wo angegeben, Verzichtserklärungen auf vorteilhafte Inhaberschaft bestehen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine director reporting shows a small sale and deferred-unit grant; ownership is concentrated across trusts and LLCs.

The Form 4 documents a disposition of 8,342 shares and an acquisition of 5 deferred stock units on 09/01/2025 by Director Susan Slavik Williams. The filing clarifies ownership is held through multiple trusts and two LLCs with varying degrees of disclaimer of beneficial ownership. This is a standard Section 16 disclosure reflecting personal and family-held structures and a typical deferred-compensation instrument for directors that converts one-for-one to common stock after service ends.

TL;DR: Insider sale is modest relative to total reported holdings; the deferred units are minor in size.

The reported sale of 8,342 shares represents a small transaction relative to the aggregate positions listed on the form, which total multiple hundreds of thousands to over a million shares across trusts and LLCs. The grant of 5 deferred stock units (expected to settle 1-for-1) is immaterial in absolute terms. The report was signed by a power of attorney on behalf of Ms. Williams and includes standard explanatory trust and LLC clarifications.

Susan Slavik Williams, membro del consiglio di amministrazione di W.W. Grainger, Inc. (GWW), ha segnalato operazioni il 01/09/2025 che mostrano una vendita e varie voci di proprietà beneficiaria. La dichiarazione indica la cessione di 8.342 azioni ordinarie Grainger e l'acquisizione di 5 unità azionarie differite, che dovrebbero convertirsi in azioni ordinarie in proporzione 1:1 al termine del mandato da direttrice. Il rapporto specifica le detenzioni complessive dirette e indirette, incluse 5.132 azioni detenute direttamente in trust, diversi trust con 48.939, 200.314, 572 e 852.158 azioni, e posizioni detenute da LLC pari a 1.528.585 e 150.000 azioni, con alcuni trust gestiti dalla signora Williams o dal marito e con i relativi disclaimer di proprietà beneficiaria dove indicati.

Susan Slavik Williams, directora de W.W. Grainger, Inc. (GWW), informó transacciones el 01/09/2025 que muestran una venta y varias entradas de propiedad beneficiaria. La presentación revela la enajenación de 8.342 acciones ordinarias de Grainger y la adquisición de 5 unidades de acciones diferidas, que se espera se conviertan una a una en acciones ordinarias al finalizar su cargo como directora. El informe enumera las participaciones totales directas e indirectas, incluidas 5.132 acciones mantenidas directamente en un fideicomiso, varios fideicomisos con 48.939, 200.314, 572 y 852.158 acciones, y posiciones en LLC de 1.528.585 y 150.000 acciones, con algunos fideicomisos administrados por la Sra. Williams o su cónyuge y con las renuncias de propiedad beneficiaria donde se indica.

W.W. Grainger, Inc.(GWW) 이사인 수잔 슬라빅 윌리엄스가 2025-09-01에 매도 및 여러 수익적 소유권 항목을 보고했습니다. 제출서는 Grainger 보통주 8,342주 처분과 5개의 이연주식단위 취득을 공시했으며, 이 단위들은 이사 임기 종료 시 1대1로 보통주로 정산될 예정입니다. 보고서는 직접·간접 계좌 전체 보유를 나열하며, 신탁에 직접 보유된 5,132주, 각기 48,939, 200,314, 572, 852,158 주를 보유한 여러 신탁, 그리고 LLC가 보유한 1,528,585주 및 150,000주 포지션을 포함하고 일부 신탁은 윌리엄스 씨 또는 그녀의 남편이 관리하며 명시된 경우 수익적 소유권 포기에 대한 고지가 있습니다.

Susan Slavik Williams, administratrice de W.W. Grainger, Inc. (GWW), a déclaré des opérations le 01/09/2025 faisant état d’une vente et de plusieurs éléments de propriété bénéficiaire. Le dépôt révèle la cession de 8 342 actions ordinaires Grainger et l’acquisition de 5 unités d’actions différées, qui devraient être converties au pair en actions ordinaires à la fin de son mandat d’administratrice. Le rapport énumère les avoirs totaux directs et indirects, y compris 5 132 actions détenues directement en trust, plusieurs trusts détenant 48 939, 200 314, 572 et 852 158 actions, et des positions détenues par des LLC de 1 528 585 et 150 000 actions, certains trusts étant gérés par Mme Williams ou son époux et comportant des déclarations de non-ingérence de propriété bénéficiaire le cas échéant.

Susan Slavik Williams, Direktorin von W.W. Grainger, Inc. (GWW), meldete am 01.09.2025 Transaktionen, die einen Verkauf und mehrere Angaben zur vorteilhaften Inhaberschaft zeigen. Die Meldung weist die Veräußerung von 8.342 Aktien der Grainger-Stammaktien und den Erwerb von 5 aufgeschobenen Aktieneinheiten aus, die voraussichtlich nach Beendigung des Direktoramts eins zu eins in Stammaktien umgewandelt werden. Der Bericht listet die gesamten direkten und indirekten Bestände auf, darunter 5.132 Aktien direkt in einem Trust gehalten, mehrere Trusts mit 48.939, 200.314, 572 und 852.158 Aktien sowie LLC-Bestände von 1.528.585 und 150.000 Aktien, wobei bestimmte Trusts von Frau Williams oder ihrem Ehemann verwaltet werden und dort, wo angegeben, Verzichtserklärungen auf vorteilhafte Inhaberschaft bestehen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Williams Susan Slavik

(Last) (First) (Middle)
100 GRAINGER PARKWAY

(Street)
LAKE FOREST IL 60045

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
W.W. GRAINGER, INC. [ GWW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 8,342 D
Common Stock 5,132 I In Trust(1)
Common Stock 48,939 I In Trust(2)
Common Stock 200,314 I In Trust(2)
Common Stock 572 I In Trust(3)
Common Stock 852,158 I In Trust(4)
Common Stock 1,528,585 I By LLC(5)
Common Stock 150,000 I By LLC(6)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Units (7) 09/01/2025 A 5 (8) (8) Common Stock 5 $1,013.5 2,166 D
Explanation of Responses:
1. Shares held in a trust for which Ms. Slavik Williams serves as trustee and she and her immediate family are beneficiaries. She disclaims beneficial ownership of such shares except to the extent of her actual pecuniary interest in such shares.
2. Shares held in trusts for which Ms. Slavik Williams serves as trustee and is the sole beneficiary.
3. Shares held in a trust for which Ms. Slavik Williams' husband serves as trustee and her immediate family are beneficiaries. Ms. Slavik Williams disclaims beneficial ownership of such shares.
4. Shares held in a trust for which Ms. Slavik Williams' husband serves as trustee and her immediate family are beneficiaries. Ms. Slavik Williams disclaims beneficial ownership of such shares.
5. Shares held by a limited liability company of which Ms. Slavik Williams is the sole manager. Ms. Williams disclaims beneficial ownership of such shares except to the extent of her actual pecuniary interest therein.
6. Shares held by a limited liability company of which Ms. Slavik Williams is the sole manager. The membership interests are held for the benefit of her children.
7. 1-for-1
8. The deferred stock units are expected to settle in shares of common stock on a one-for-one basis following end of service as a director.
Remarks:
Exhibits: Exhibit 24 - Power of Attorney.
/s/ Paul Stanukinas, by POA from Susan Slavik Williams, Director 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Susan Slavik Williams report on Form 4 for GWW?

The Form 4 reports a disposition of 8,342 shares of W.W. Grainger common stock and an acquisition of 5 deferred stock units on 09/01/2025.

How many Grainger shares does the filing show held in trusts or LLCs?

The filing lists trust and LLC holdings including 5,132, 48,939, 200,314, 572, 852,158, 1,528,585, and 150,000 shares across various trusts and two LLCs.

Do any parties disclaim beneficial ownership in this Form 4?

Yes. The filing states Ms. Williams disclaims beneficial ownership for several trusts and for certain LLC-held shares except to the extent of her actual pecuniary interest, and notes some trusts are administered by her husband.

When will the deferred stock units settle into common stock?

The filing states the deferred stock units are expected to settle on a one-for-one basis into common stock following the end of Ms. Williams' service as a director.

Who signed the Form 4 filing?

The signature block shows Paul Stanukinas signed by power of attorney on behalf of Susan Slavik Williams on 09/03/2025.
WW Grainger

NYSE:GWW

GWW Rankings

GWW Latest News

GWW Latest SEC Filings

GWW Stock Data

49.17B
44.88M
6.16%
74.34%
2.04%
Industrial Distribution
Wholesale-durable Goods
Link
United States
LAKE FOREST